Article

jdsupra.com on 2020-02-10 19:38

Increasing Competition in the Biologic Market Through Truthful Advertising

This past week, FTC and FDA have taken further steps to encourage robust biosimilar competition in 2020 and beyond, this time with a particular focus ...

Related news

Increasing Energy Access through Off-Grid Solutions jdsupra.com
California , United States , Switzerland
Increasing Health Awareness through Hip Hop Music jdsupra.com
California , United States , Switzerland
Biologic and Biosimilar Litigation Updates jdsupra.com
California , United States , Switzerland
Biosimilar and Biologic Development Updates jdsupra.com
California , United States , Switzerland
California Supreme Court: No Right to Jury in Unfair Competition, False Advertising Cases jdsupra.com
California , United States , Switzerland
California: No Jury Trials in Unfair Competition Law and False Advertising Law Cases (and Proposition 65 Cases?)jdsupra.com
United States , Switzerland , California
Biosimilar and Biologic Business Developments Update – Collaborations and Licensing Deals jdsupra.com
California , United States , Switzerland
First competition fine imposed for ban on online search advertising - The European Commission has fined fashion company Guess almost €40m for restricting its authorised retailers from advertising the brand online and making cross-border sales.jdsupra.com
California , United States , Switzerland , Germany
FDA’s New Draft Biologic Naming Guidance jdsupra.com
California , United States , Switzerland
Cut through the fiduciary advertising and make sure you get what you were promised jdsupra.com
California , United States , Switzerland
Reforming America’s Healthcare System Through Choice and Competition: The Trump Administration Recommends Healthcare De-Regulation jdsupra.com
California , United States , Switzerland
Trump’s Administration Plans to Fix U.S. Healthcare System through Choice and Competition jdsupra.com
California , United States , Switzerland
Cannabis Advertising jdsupra.com
California , United States , Switzerland
The Mexican Competition Commission enacts emergency regulatory provisions governing service of process through e-mail during the pandemic jdsupra.com
California , United States , Switzerland
Former Genentech Employees Accused of Stealing Biologic Manufacturing Process Trade Secrets jdsupra.com
California , United States , Switzerland
Biologic and Biosimilar Settlement Agreements Now Must Be Disclosed to DOJ and FTC jdsupra.com
California , United States , Switzerland , The Settlement
Health Canada Drops Suffix in Biologic and Biosimilar Naming Convention jdsupra.com
California , United States , Switzerland
Beware “Natural” Advertising jdsupra.com
California , United States , Switzerland
Antitrust Alert: New Law Requires Disclosure of Biologic Patent Settlement Agreements to Antitrust Authorities jdsupra.com
California , United States , Switzerland , The Settlement
Biosimilar and Biologic Updates in China: Bevacizumab, Etanercept, Tislezumab, Infliximab, Eculizumab, Adalimumab jdsupra.com
California , United States , Switzerland , China